Event Videos

https://pubmed.ncbi.nlm.nih.gov/38374561/ liver transplant
Multicenter Study

J Pediatr Gastroenterol Nutr. 2024 Feb;78(2):328-338.
doi: 10.1002/jpn3.12112. Epub 2024 Jan 2.

Impact of early immunosuppression on pediatric liver transplant outcomes within 1 year

Vikram K Raghu 1, Xingyu Zhang 2, James E Squires 1, Elizabeth Eisenberg 3, Amy G Feldman 4, Jennifer Halma 5, Anna L Peters 6 7, Regino P Gonzalez-Peralta 8, Vicky L Ng 9, Simon P Horslen 1, Steven J Lobritto 10, John Bucuvalas 11, George V Mazariegos 2, Emily R Perito 12

Abstract

Published on: 
Feb-2024

https://pubmed.ncbi.nlm.nih.gov/38291686/ cystic fibrosis

J Pediatr Gastroenterol Nutr. 2024 Jan;78(1):153-165.
doi: 10.1097/MPG.0000000000003944.

Towards a Standardized Classification of the Hepatobiliary Manifestations in Cystic Fibrosis (CFHBI): A Joint ESPGHAN/NASPGHAN Position Paper

Frank A J A Bodewes 1, Alvin Jay Freeman 2, Alexander Weymann 3, Dominique Debray 4, Isabelle Scheers 5, Henkjan J Verkade 1, Michael R Narkewicz 6

Abstract

Published on: 
Jan-2024

https://pubmed.ncbi.nlm.nih.gov/38374552/ Liver transplant

Randomized Controlled Trial

J Pediatr Gastroenterol Nutr. 2024 Feb;78(2):350-359.
doi: 10.1002/jpn3.12077. Epub 2023 Dec 11.

Midodrine reduces new-onset acute kidney injury and hyponatremia in children with cirrhosis and ascites awaiting liver transplantation: Results from an open-label RCT

A Ashritha 1, Bikrant B Lal 1, Rajeev Khanna 1, Vikrant Sood 1, Arun K Sood 1, Seema Alam 1

Abstract

Published on: 
Feb-2024

https://pubmed.ncbi.nlm.nih.gov/38291699/ NAFLD

J Pediatr Gastroenterol Nutr. 2024 Jan;78(1):27-35.
doi: 10.1002/jpn3.12068. Epub 2023 Dec 29.

Noninvasive scores are poorly predictive of histological fibrosis in paediatric fatty liver disease

Laura Kalveram 1, Ulrich Baumann 2 3, Ruth De Bruyne 4, Laura Draijer 5, Wojciech Janczyk 6, Deirdre Kelly 7, Bart G Koot 5, Florence Lacaille 8, Sander Lefere 9, Hadar Moran Lev 10, Judith Lubrecht 11, Jake P Mann 7, Antonella Mosca 12, Sanjay Rajwal 13, Piotr Socha 6, Anita Vreugdenhil 11, Anna Alisi 14, Christian A Hudert 1; ESPGHAN Fatty Liver Special Interest Group

Abstract

Published on: 
Jan-2024

https://pubmed.ncbi.nlm.nih.gov/38374548/ acute liver failure
J Pediatr Gastroenterol Nutr. 2024 Feb;78(2):320-327.
doi: 10.1002/jpn3.12094.Epub 2023 Dec 12.

Improved mortality prediction for pediatric acute liver failure using dynamic prediction strategy

Ruosha Li 1, Jingyan Wang 1, Cuihong Zhang 1, James E Squires 2, Steven H Belle 3, Jing Ning 4, Jianwen Cai 5, Robert H Squires 2

Abstract
Objectives: To develop and validate a prediction tool for pediatric acute liver failure (PALF) mortality risks that captures the rapid and heterogeneous clinical course for accurate and updated prediction.

Published on: 
Feb-2024

https://pubmed.ncbi.nlm.nih.gov/38278482/ NAFLD

Acad Pediatr. 2024 Jan 24:S1876-2859(24)00018-4.
doi: 10.1016/j.acap.2024.01.019.Online ahead of print.

Missed Opportunities in Guideline-based Fatty Liver Screening among 3.5 million children

Reema Gulati 1, Kabir Gulati 2, Naim Alkhouri 3, Herman Sahni 4, Maroun J Mhanna 5, David C Kaelber 1, Hafiza Mehreen Durrani 1, Roamaa Suri 6
Affiliations expand
PMID: 38278482

DOI: 10.1016/j.acap.2024.01.019
Abstract

Objective: Determine screening rates and examine socio- demographic characteristics of MAFLD screening in a large population of obese children.

Published on: 
Jan-2024

https://pubmed.ncbi.nlm.nih.gov/38369891/ hepatitis C

J Pediatr Gastroenterol Nutr. 2024 Feb 18.

doi: 10.1002/jpn3.12160. Online ahead of print.

ESPGHAN recommendations on treatment of chronic hepatitis C virus infection in adolescents and children including those living in resource-limited settings

Giuseppe Indolfi 1 2, Regino P Gonzalez-Peralta 3, Maureen M Jonas 4, Manal Hamdy-El Sayed 5, Björn Fischler 6, Etienne Sokal 7, Stefan Wirth 8, Emanuele Nicastro 9; Hepatology Committee of the ESPGHAN

Abstract

Published on: 
Feb-2024

https://pubmed.ncbi.nlm.nih.gov/38283704/ Hepatitis B

J Clin Exp Hepatol. 2024 May-Jun;14(3):101336.
doi: 10.1016/j.jceh.2023.101336.Epub 2023 Dec 19.

Hepatitis B in Trans-Himalayan Tribal Population: High Prevalence, High Pediatric Burden, Virologic Patterns, and Implications for Public Health Interventions

Brij Sharma 1, Vishal Bodh 1, Neetu Sharma 2, Rajesh Sharma 1, Amit Sachdeva 3, Anmol Gupta 3, Anil Kanga 4, Dikshant Sharma 5, Ashish Chauhan 1

Abstract
Background/aims: The prevalence of hepatitis B is higher in tribal populations, compared to non-tribal populations in India. Therefore, this study aimed to investigate the risk factors, virological and biochemical profile of patients with hepatitis B in a tribal population.

Published on: 
Jan-2024

https://pubmed.ncbi.nlm.nih.gov/38291698/ Budd-chiari syndrome

J Pediatr Gastroenterol Nutr. 2024 Jan;78(1):17-26.
doi: 10.1002/jpn3.12067. Epub 2023 Dec 6.

Budd-Chiari syndrome in children: Radiological intervention and role of shear wave elastography in monitoring response

Arghya Samanta 1, Anshu Srivastava 1, Rajnikant Yadav 2, Aditya Kapoor 3, Anindya Ghosh 3, Prabhakar Mishra 4, Moinak Sen Sarma 1, Ujjal Poddar 1

Abstract

Objectives: Radiological intervention (RI) is the preferred treatment in children with Budd-Chiari syndrome (BCS). We studied the comparative long-term outcome of BCS children, with and without RI and utility of liver and splenic stiffness measurement (LSM, SSM) by 2-dimensional shear wave elastography (2D-SWE) in assessing response.

Published on: 
Jan-2024

https://pubmed.ncbi.nlm.nih.gov/38284625/ PFIC

Biofactors. 2024 Jan 29.
doi: 10.1002/biof.2041. Online ahead of print.

Molecular basis of progressive familial intrahepatic cholestasis 3. A proteomics study

Laura Guerrero 1, Lorena Carmona-Rodríguez 1, Fátima Milhano Santos 1, Sergio Ciordia 1, Luiz Stark 2, Loreto Hierro 2, Pablo Pérez-Montero 3, David Vicent 2, Fernando J Corrales 1

Abstract

Published on: 
Jan-2024

CLF Intro movie

Financial Aid Offered by Trusts

Follow us on: